Atle Fund Management AB
Filing Date
Global Rank
#2,715
/ 8,603
▲ 691
· as of Mar 2026
Top Industry
Biotechnology
43.7%
3Y Alpha vs SPY
-11.2%
Period ended 3 months ago
Filed May 11, 2026 · 59d
19 quarters · since Dec 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+32.9%
SPY
+76.0%
Annualised alpha
-10.8%
Max drawdown
−20.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
39 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
13.0%
+2.3 pts
Top 5
40.9%
+6.1 pts
Top 10
63.1%
+10.4 pts
HHI
538
Diversified+115
Portfolio Trend
19 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $463,383,762 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
13 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | +1,058,271 | 1,169,634 | $23,264,020 | |
| DXCM | Dexcom Inc | +544,610 | 584,332 | $36,696,049 | |
| RVMD | Revolution Medicines, Inc. | +527,061 | 617,245 | $60,027,076 | |
| MIRM | Mirum Pharmaceuticals, Inc. | +106,083 | 195,768 | $18,085,047 | |
| CELC | Celcuity Inc. | +99,465 | 141,296 | $16,127,525 | |
| CAH | Cardinal Health Inc | +85,212 | 108,682 | $22,965,593 | |
| INSM | INSMED Inc | +69,565 | 97,438 | $15,933,061 | |
| IRON | Disc Medicine, Inc. | +59,288 | 107,255 | $6,857,884 | |
| ISRG | Intuitive Surgical Inc | +48,529 | 70,851 | $32,661,602 | |
| SLNO | Soleno Therapeutics Inc | +27,449 | 90,184 | $3,019,360 | |
| LLY | ELI LILLY & Co | +8,589 | 39,722 | $36,535,103 | |
| KRYS | Krystal Biotech, Inc. | +3,726 | 37,579 | $9,707,407 | |
| ONC | BeOne Medicines Ltd. | +1,285 | 41,717 | $12,388,697 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
15 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | −542,501 | 41,831 | $221,285 | |
| PYXS | Pyxis Oncology, Inc. | −420,209 | 197,036 | $287,672 | |
| MRK | Merck & Co., Inc. | −161,915 | 33,853 | $4,072,177 | |
| NAMS | NewAmsterdam Pharma Co N.V. | −102,240 | 94,796 | $3,034,419 | |
| CVS | CVS HEALTH Corp | −82,745 | 23,773 | $1,707,376 | |
| BSX | Boston Scientific Corp | −68,250 | 40,432 | $2,537,108 | |
| IDYA | IDEAYA Biosciences, Inc. | −66,305 | 31,133 | $1,037,351 | |
| IONS | Ionis Pharmaceuticals Inc | −64,504 | 27,873 | $2,092,983 | |
| BBIO | BridgeBio Pharma, Inc. | −29,933 | 111,363 | $8,269,816 | |
| INCY | Incyte Corp | −20,055 | 50,796 | $4,780,919 | |
| IRTC | iRhythm Holdings, Inc. | −15,257 | 22,322 | $2,634,442 | |
| TMO | Thermo Fisher Scientific Inc. | −6,929 | 22,986 | $11,298,308 | |
| NBIX | Neurocrine Biosciences Inc | −5,111 | 89,685 | $11,815,101 | |
| GILD | Gilead Sciences, Inc. | −2,829 | 47,967 | $6,685,160 | |
| COR | Cencora, Inc. | −303 | 23,470 | $7,372,865 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
4 positions
Sold Out
Positions the filer fully exited
4 positions
39 positions ·
$463,383,762 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 617,245 | $60,027,076 | 12.95% | |
| DXCM |
Dexcom Inc
Healthcare
|
Added | 584,332 | $36,696,049 | 7.92% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Added | 39,722 | $36,535,103 | 7.88% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Added | 70,851 | $32,661,602 | 7.05% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Held | 108,181 | $23,528,285 | 5.08% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 1,169,634 | $23,264,020 | 5.02% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Added | 108,682 | $22,965,593 | 4.96% | |
| JNJ |
Johnson & Johnson
Healthcare
|
NEW | 92,377 | $22,580,633 | 4.87% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Added | 195,768 | $18,085,047 | 3.90% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 141,296 | $16,127,525 | 3.48% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 97,438 | $15,933,061 | 3.44% | |
| ONC |
BeOne Medicines Ltd.
Healthcare
|
Added | 41,717 | $12,388,697 | 2.67% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Reduced | 89,685 | $11,815,101 | 2.55% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Reduced | 22,986 | $11,298,308 | 2.44% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Held | 22,984 | $10,263,275 | 2.21% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Added | 37,579 | $9,707,407 | 2.09% | |
| SYK |
Stryker Corp
Healthcare
|
Held | 26,835 | $8,817,712 | 1.90% | |
| ALKS |
Alkermes plc.
Healthcare
|
Held | 242,473 | $8,573,845 | 1.85% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
NEW | 106,518 | $8,529,961 | 1.84% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 111,363 | $8,269,816 | 1.78% | |
| AMGN |
Amgen Inc
Healthcare
|
Held | 21,903 | $7,706,570 | 1.66% | |
| COR |
Cencora, Inc.
Healthcare
|
Reduced | 23,470 | $7,372,865 | 1.59% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 107,255 | $6,857,884 | 1.48% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Reduced | 47,967 | $6,685,160 | 1.44% | |
| INCY |
Incyte Corp
Healthcare
|
Reduced | 50,796 | $4,780,919 | 1.03% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Reduced | 33,853 | $4,072,177 | 0.88% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Held | 14,636 | $3,960,355 | 0.85% | |
| ABVX |
Abivax S.A.
Healthcare
|
Held | 31,590 | $3,517,546 | 0.76% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
NEW | 62,735 | $3,164,353 | 0.68% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Reduced | 94,796 | $3,034,419 | 0.65% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Added | 90,184 | $3,019,360 | 0.65% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Reduced | 22,322 | $2,634,442 | 0.57% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Reduced | 40,432 | $2,537,108 | 0.55% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Reduced | 27,873 | $2,092,983 | 0.45% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Reduced | 23,773 | $1,707,376 | 0.37% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Reduced | 31,133 | $1,037,351 | 0.22% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 29,915 | $625,821 | 0.14% | |
| PYXS |
Pyxis Oncology, Inc.
Healthcare
|
Reduced | 197,036 | $287,672 | 0.06% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 41,831 | $221,285 | 0.05% |